Laws · state-regulation

Utah Opens Comment Window on Medical Cannabis Rules Through Dec. 15

Operators, patients and tax advisers have until December 15 to weigh in on Utah's proposed medical cannabis rules, and the filing details matter more than the headline.

By Priya Subramanian, Tax & Compliance ReporterPublished November 21, 20266 min read
A breathtaking aerial view of Salt Lake City at night featuring a vibrant skyline and illuminated buildings.

A breathtaking aerial view of Salt Lake City at night featuring a vibrant skyline and illuminated buildings.

Utah's medical cannabis rulemaking is open for public comment through December 15, according to a Cannabis Aficionado report dated November 21. Licensees, patients and tax advisers have a narrow window to shape rules that govern compliance costs and deductible expenses.

The comment window is short and the deadline is fixed

Utah's proposed medical cannabis rules are open for public comment until December 15, according to a Cannabis Aficionado report published November 21.

That leaves roughly three and a half weeks from the date of the report. In state administrative practice, a comment deadline is a hard procedural line. Submissions that arrive after it generally don't enter the rulemaking record.

All CannIntel has to work with is a headline and a publication date. It doesn't identify the specific rule sections, the agency docket number, or the text of the proposal, and we won't guess at those details. Pull the proposed text directly from the state's administrative rules filing before drafting anything.

That caveat shapes everything below. What follows is a framework for reading the proposal, not a summary of it.

Who in Utah's program has standing to comment

Any stakeholder affected by the rules can submit comments, but the record rewards specificity over volume.

Utah runs a tightly controlled medical program. Under Utah's Medical Cannabis Act, the state limits the number of licensed operators and routes patient products through state-regulated channels. A small number of licensees therefore carry most of the compliance burden, and they have the most to gain or lose from any rule text.

Four groups should be reading the draft closely:

  • Cultivators and processors, whose inventory tracking, testing and packaging obligations usually sit in the rules rather than the statute.
  • Pharmacies and dispensing entities, which face the day-to-day operational mandates.
  • Patients and caregivers, whose access depends on card, recommendation and purchase-limit provisions.
  • Accountants and compliance counsel, who translate rule language into cost structures and tax positions.

Regulators tend to weigh comments that cite a specific rule section and propose replacement text. A general objection to a program is easy to set aside. A line-edit with a cost figure isn't.

Why the tax reader should care about operational rules

On a strict reading of IRC §280E, the way a state rule characterizes an expense can decide whether that expense is deductible at all.

Section 280E of the Internal Revenue Code bars any deduction or credit for amounts paid in carrying on a trade or business that consists of trafficking in Schedule I or II controlled substances. Marijuana remains in Schedule I. The statute doesn't carve out medical programs, so Utah licensees are covered by its text as written.

The operative workaround is cost of goods sold. COGS isn't a deduction under the Code. It's an adjustment to gross receipts. Under IRC §471, a taxpayer reduces gross receipts by the cost of inventory before computing gross income. The IRS and the courts have allowed that adjustment for plant-touching businesses, though the scope of allowable inventory costs is narrower for resellers than for producers.

Here's where a state rulemaking becomes a tax document. When a rule mandates a given activity, such as lab testing, packaging, security, or seed-to-sale tracking, it affects how an operator can argue that cost belongs in inventory rather than in nondeductible overhead. A rule that ties a requirement directly to production or to the acquisition of goods for resale supports an inventoriable-cost position, while a rule that frames the same requirement as general business administration does the opposite.

It's a technical point, but it's real money. Operators who miss it will find out at audit.

A comment that asks the state to describe a compliance cost as part of production or inventory handling, rather than as general administration, can give a licensee's tax position firmer footing later.

What to look for in the proposed text

The highest-value comments target definitions, cost-bearing mandates and effective dates.

Without the draft in front of us, here's a checklist that applies to almost any state medical cannabis rulemaking. Treat it as a reading guide:

  1. Definitions section. Terms like "production," "processing" and "inventory" carry downstream weight. Vague definitions invite inconsistent enforcement and inconsistent tax treatment.
  2. Testing and packaging mandates. These are classic inventoriable costs for producers. Check whether the rule requires them before sale, since timing affects when the cost attaches to goods.
  3. Tracking and recordkeeping. Seed-to-sale requirements generate the documentation that supports a COGS claim. Strong state recordkeeping rules can help a licensee's audit file.
  4. Fee schedules. License, renewal and registration fees are usually nondeductible under §280E for plant-touching operators, though portions may be argued into inventory. Put the fee amounts in your cost model now.
  5. Effective and compliance dates. A short phase-in forces capital spending into a narrow period. If the numbers don't work, ask for a longer runway.

Compare the proposed text against the current rule line by line. Changes, not carried-over language, are what move the economics.

How to file and what comes next

File in writing, cite section numbers, and keep proof of submission before December 15.

Utah posts proposed rules through its state administrative rules process, and the agency identified in the proposal sets the submission method. Confirm the channel, whether email, web form or mail, from the official notice rather than from a secondary report.

Practical steps for operators and advisers:

  • Quantify the cost impact in dollars where you can. Regulators respond to numbers.
  • Separate legal objections from operational ones. Different staff often review them.
  • Keep a dated copy of your submission for your own compliance file.

For full background on how the state's program has developed, see the CannIntel topic hub on Utah medical cannabis rules. Utah's program sits alongside a patchwork of other state systems, from California's DCC to Ohio's Division of Cannabis Control, and each treats cost documentation differently.

Once the comment period closes, the agency reviews submissions and may revise the text before finalizing. The proposal can change, or it can pass largely intact. Either way, the record is set on December 15.

The next signal to watch is whether the agency publishes a revised draft or a summary of comments before the rules take effect. That document will show which stakeholder arguments landed.

Sources

Utah medical cannabisIRC 280Epublic comment periodstate cannabis rulemakingcost of goods soldcannabis compliance
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Laws

More from the newsroom